Gazette.govt.nzIn the notice with the above heading, published in the New Zealand Gazette, 22 April 2021, Notice No. 2021-go1438. This corrigendum amends the notice by replacing the entry:
Schedule
| Product: Amino acid component: Active Ingredients: |
SmofKabiven Low Osmo Alanine 14g/L Arginine 12g/L Calcium chloride dihydrate 0.74g/L equivalent to calcium chloride 0.56g/L Glycine 11g/L Histidine 3g/L Isoleucine 5g/L Leucine 7.4g/L Lysine acetate 9.3g/L equivalent to L-Lysine 6.6g/L Magnesium sulfate heptahydrate 2.47g/L equivalent to magnesium sulfate 1.2g/L Methionine 4.3g/L Phenylalanine 5.1g/L Potassium chloride 4.48g/L Proline 11.2g/L Serine 6.5g/L Sodium acetate trihydrate 5.62g/L equivalent to sodium acetate 3.4g/L Sodium glycerophosphate 4.18mg/L Taurine 1g/L Threonine 4.4g/L Tryptophan 2g/L Tyrosine 0.4g/L Valine 6.2g/L Zinc sulfate heptahydrate 0.023g/L equivalent to zinc sulfate 0.0129g/L |
| Dosage Form: | Solution for infusion |
| Glucose component: Active Ingredient: |
Glucose monohydrate 130g/L equivalent to glucose 118g/L |
| Dosage Form: | Solution for infusion |
| Lipid component: Active Ingredients: |
Fish oil 30g/L Medium-chain triglycerides 60g/L Olive oil 50g/L Soya oil 60g/L |
| Dosage Form: | Emulsion for infusion |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Fresenius Kabi AB, Uppsala, Sweden |
With:
| Product: Amino acid component: Active Ingredients: |
SmofKabiven Low Osmo Alanine 14g/L Arginine 12g/L Calcium chloride dihydrate 0.74g/L equivalent to calcium chloride 0.56g/L Glycine 11g/L Histidine 3g/L Isoleucine 5g/L Leucine 7.4g/L Lysine acetate 9.3g/L equivalent to L-Lysine 6.6g/L Magnesium sulfate heptahydrate 2.47g/L equivalent to magnesium sulfate 1.2g/L Methionine 4.3g/L Phenylalanine 5.1g/L Potassium chloride 4.48g/L Proline 11.2g/L Serine 6.5g/L Sodium acetate trihydrate 5.62g/L equivalent to sodium acetate 3.4g/L Sodium glycerophosphate 4.18g/L Taurine 1g/L Threonine 4.4g/L Tryptophan 2g/L Tyrosine 0.4g/L Valine 6.2g/L Zinc sulfate heptahydrate 0.023g/L equivalent to zinc sulfate 0.0129g/L |
| Dosage Form: | Solution for infusion |
| Glucose component: Active Ingredient: |
Glucose monohydrate 130g/L equivalent to glucose 118g/L |
| Dosage Form: | Solution for infusion |
| Lipid component: Active Ingredients: |
Fish oil 30g/L Medium-chain triglycerides 60g/L Olive oil 50g/L Soya oil 60g/L |
| Dosage Form: | Emulsion for infusion |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Fresenius Kabi AB, Uppsala, Sweden |
Dated this 5th day of July 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).